The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure
- 1 June 1978
- journal article
- clinical trial
- Published by Oxford University Press (OUP)
- Vol. 54 (632), 405-409
- https://doi.org/10.1136/pgmj.54.632.405
Abstract
Summary: Extra potassium supplements, spironolactone or amiloride were given for 5 months to forty-nine patients with heart failure who were taking furosemide and were in a steady state. Plasma potassium increased with all three treatments but there was no significant increase in total body potassium or red cell potassium. These findings together with other studies suggest that patients with heart failure taking diuretics do not have a significant depletion of body potassium.Keywords
This publication has 11 references indexed in Scilit:
- Potassium depletion in heart failure and its relation to long-term treatment with diuretics: a review of the literaturePublished by Oxford University Press (OUP) ,1978
- Potassium in heart failure.BMJ, 1977
- EFFECT OF LONG-TERM DIURETIC TREATMENT ON BODY-POTASSIUM IN HEART-DISEASEThe Lancet, 1976
- Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.Heart, 1976
- POTASSIUM SUPPLEMENTS IN PATIENTS RECEIVING LONG-TERM DIURETICS FOR EDEMA1976
- COMPARISON OF THE POTASSIUM-RETAINING EFFECTS OF AMILORIDE AND SPIRONOLACTONE IN HYPERTENSIVE PATIENTS WITH THIAZIDE-INDUCED HYPOKALÆMIAThe Lancet, 1973
- Use of amiloride as a potassium conserving agent in severe cardiac disease.Heart, 1973
- FATE OF POTASSIUM SUPPLEMENTS IN SIX OUTPATIENTS RECEIVING LONG-TERM DIURETICS FOR ŒDEMATOUS DISEASEThe Lancet, 1972
- Effect of Potassium Supplements on the Exchangeable Potassium in Chronic Heart DiseaseBMJ, 1970
- EXCHANGEABLE POTASSIUM IN WASTING, AMYOTROPHY, HEART-DISEASE, AND CIRRHOSIS OF THE LIVERThe Lancet, 1961